Yahoo! Finance: QGEN News

QIAGEN Added to NASDAQ-100 Index (GlobeNewswire)

Mon, 14 Dec 2009 09:00:00 Etc/GMT

VENLO, The Netherlands -- QIAGEN N.V. today announced that its common shares will be included in the NASDAQ-100 Index effective as of the start of trading on December 21, 2009. The NASDAQ-100 Index comprises the top 100 non-financial securities listed on The NASDAQ Stock Market based on market capitalization.

QIAGEN Announces Closing of the Acquisition of SABiosciences (Marketwire)

Mon, 14 Dec 2009 07:13:00 Etc/GMT

NASDAQ Announces the Annual Re-Ranking of the NASDAQ-100 Index (GlobeNewswire)

Sat, 12 Dec 2009 01:05:00 Etc/GMT

NEW YORK -- The NASDAQ OMX Group, Inc. announced today the annual re-ranking of the NASDAQ-100 Index, effective with the market open on Monday, December 21, 2009.

Better Buy: QIAGEN N.V. or Gen-Probe? (at Motley Fool)

Tue, 8 Dec 2009 19:48:06 Etc/GMT

Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst (Wall Street Transcript)

Fri, 20 Nov 2009 14:44:00 Etc/GMT

Q3 2009 Qiagen N.V. Earnings Release - Time Not Supplied (CCBN)

Tue, 10 Nov 2009 12:07:16 Etc/GMT

QIAGEN to Acquire SABiosciences (Marketwire)

Mon, 9 Nov 2009 21:26:00 Etc/GMT

QIAGEN Reports Strong Third Quarter 2009 Results (GlobeNewswire)

Mon, 9 Nov 2009 21:00:00 Etc/GMT

VENLO, The Netherlands -- QIAGEN N.V. today announced the results of operations for the third quarter and the nine-month period ended September 30, 2009.

Healthcare Bill Will Be Law By New Year Says Morningstar Strategist (Wall Street Transcript)

Mon, 9 Nov 2009 18:50:00 Etc/GMT

67 WALL STREET, New York - November 9, 2009 - The Wall Street Transcript has just published its Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This 76 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

[$$] Stocks Jump Despite Rising Unemployment (at Barrons.com)

Sat, 7 Nov 2009 11:02:04 Etc/GMT

Stocks Jump Despite Rising Unemployment Mixed data leave some investors wary -- yet indexes manage to reverse two weeks' decline.

QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing (Business Wire)

Thu, 5 Nov 2009 07:30:00 Etc/GMT

VENLO, Netherlands----QIAGEN today announced an expansion of its strategic partnership with the United Kingdom’s Veterinary Laboratories Agency , one of the world’s leading research institutions in veterinary science.

Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2009 Financial Results Call Set for November 10 (PR Newswire)

Tue, 3 Nov 2009 13:00:00 Etc/GMT

QIAGEN N.V. today announced the Webcast of its third quarter 2009 financial results call. The Webcast will take place at 9:30 a.m. EST on Tuesday, November 10, and will include remarks by Peer M.

Neurogenic Orthostatic Hypotension Treatment Should Pass Phase III Trials: Catalyst For Biotech Stock Says Wedbush Morgan Analyst (Wall Street Transcript)

Tue, 20 Oct 2009 15:55:00 Etc/GMT

67 WALL STREET, New York - October 20, 2009 - The Wall Street Transcript has just published its Biotechnology Report offering a timely review of the sector to serious investors and industry executives. This 70 page feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

Coverage initiated on Qiagen by Barclays Capital (Briefing.com)

Wed, 7 Oct 2009 10:11:11 Etc/GMT

Denosumab and GAMMAGARD Will Unlock The Upside For Amgen and Baxter According To Large Cap Growth Stock Pickers At Kellogg Asset Management (Wall Street Transcript)

Mon, 5 Oct 2009 11:30:00 Etc/GMT

67 WALL STREET, New York - October 4, 2009 - The Wall Street Transcript has just published its TWST Large Cap Growth Report offering a timely review of the sector to serious investors and industry executives. This 43 page feature contains expert industry commentary through in-depth interviews with top tier Portfolio Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

QIAGEN Announces Exercise in Full of Over-Allotment Option by Underwriters in Offering of New Common Shares (GlobeNewswire)

Tue, 29 Sep 2009 20:30:00 Etc/GMT

Biotechnology Real Estate: Industry Expert Jerry Doctrow Calls This A Sweet Spot For Investors In This Market (Wall Street Transcript)

Mon, 28 Sep 2009 15:18:00 Etc/GMT

67 WALL STREET, New York - September 28, 2009 - The Wall Street Transcript has just published its Medical Real Estate: Healthcare REITs, Long-Term Care Facilities and Hospitals Report offering a timely review of the sector to serious investors and industry executives. This 45 page feature contains expert industry commentary through 10 in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.

QIAGEN Announces Pricing of Offering of New Common Shares (GlobeNewswire)

Thu, 24 Sep 2009 23:15:00 Etc/GMT

VENLO, the Netherlands -- QIAGEN N.V. announces that it will issue 27.5 million newly issued common shares in connection with the offering announced on September 22, 2009 at a price of US$ 20.25 per share .

QIAGEN Announces An Offering of New Common Shares (GlobeNewswire)

Tue, 22 Sep 2009 20:15:00 Etc/GMT

QIAGEN Acquires DxS Ltd -- Creating Leadership in Personalized Healthcare (GlobeNewswire)

Tue, 22 Sep 2009 20:05:00 Etc/GMT